MedPlus Health Services Ltd reports unaudited Q2FY27 revenue of ₹2,037.1 crore, up 21.3% year-on-year
- Revenue rose 8.4% sequentially; gross margin was 25.1%.
- Operating EBITDA increased 10.7% year-on-year and 50.7% sequentially to ₹98.1 crore, with a 4.8% margin.
- Net profit was ₹56.1 crore, up 1.0% year-on-year and 69.1% sequentially; earnings call scheduled for October 28, 2026.
Original Filing: https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8246507a-4ed5-48ed-8920-0e508d057146.pdf